TY  - BOOK
AU  - Russomanno, Kristen L
TI  - Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives. [Review]
SN  - 1178-7015
PY  - 2023///
KW  - Automated
KW  - Dermatology
KW  - MedStar Outpatient Care
KW  - Journal Article
KW  - Review
N2  - Non-melanoma skin cancers (NMSCs) are the most common cancers worldwide and may be associated with significant morbidity and mortality, especially in immunosuppressed populations. Successful management of NMSC must take primary, secondary and tertiary prevention strategies into consideration. In response to an improved understanding of the pathophysiology of NMSC and associated risk factors, multiple systemic and topical immunomodulatory drugs have been developed and integrated into clinical practice. Many of these drugs are efficacious in the prevention and treatment of precursor lesions (actinic keratoses; AKs), low-risk NMSC, and advanced disease. The identification of patients at high risk for the development of NMSC is critical in reducing disease morbidity. Understanding the various treatment options available and their comparative effectiveness is paramount for developing a personalized treatment regimen for such patients. This review article provides an updated overview of the various topical and systemic immunomodulatory drugs available for the prevention and treatment of NMSC, and the published data supporting their use in clinical practice. Copyright © 2023 Russomanno et al
UR  - https://dx.doi.org/10.2147/CCID.S362171
ER  -